Spyre Therapeutics Added to the Nasdaq Biotechnology Index Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic...
Wednesday, December 18, 2024 1 min read
Key Takeaway: Spyre Therapeutics, Inc. has been included in the Nasdaq Biotechnology Index, which is designed to track the performance of biotechnology and pharmaceutical companies. Companies must meet specific eligibility criteria to be listed, reflecting their market capitalization and trading activity. This addition is significant for Spyre Therapeutics as it may lead to increased investor interest and market exposure. The Nasdaq Biotechnology Index is evaluated annually, indicating important milestones for companies within the sector.
Market Sentiment Analysis
POSITIVE FACTORS
Spyre Therapeutics has been added to the Nasdaq Biotechnology Index.
This inclusion reflects the company's strong performance and visibility in the market.
Being part of this index can attract more investors and enhance credibility.
Full Press Release Details
The NBI is designed to track the performance of a set of securities listed on The Nasdaq Stock Market ® that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. Companies in the Nasdaq Biotechnology Index must meet eligibility requirements, including minimum market capitalization, average daily trading volume and seasoning as a public company, among other criteria. The NBI is evaluated annually in December and is calculated under a modified capitalization-weighted methodology.
For more information about the Nasdaq Biotechnology Index, please visit this link .
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
SOURCE Spyre Therapeutics, Inc.
21 %
Frequently Asked Questions
What is the NBI?
The NBI tracks the performance of biotechnology and pharmaceutical securities listed on Nasdaq.
What criteria do companies need for the NBI?
Companies must meet requirements like minimum market cap, trading volume, and public company seasoning.
When is the NBI evaluated?
The NBI is evaluated annually in December.
How is the NBI calculated?
The NBI uses a modified capitalization-weighted methodology for calculation.
Where can I find more about the NBI?
For more details about the NBI, visit the provided link.